Dyne Therapeutics, Inc. (DYN) vs Enliven Therapeutics, Inc. (ELVN)
Dyne Therapeutics, Inc. and Enliven Therapeutics, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Enliven Therapeutics, Inc. are of similar size ($3.3B and $3.1B). Across the 10 metrics below, Enliven Therapeutics, Inc. leads on 9 and Dyne Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | DYN | ELVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (81.57%) | (15.31%) | (57.72%) |
| Return on assets | (60.29%) | (14.98%) | (49.22%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack